Status:
COMPLETED
Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity
Lead Sponsor:
S.LAB (SOLOWAYS)
Collaborating Sponsors:
Center of New Medical Technologies
Triangel Scientific
Conditions:
Overweight and Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This clinical trial investigated the combined effects of Semaglutide and a fiber supplement (glucomannan, inulin, psyllium) on weight loss in adults with overweight or obesity. Participants, aged 18-6...
Eligibility Criteria
Inclusion
- BMI ≥30, or ≥27 with comorbidities.
Exclusion
- Serious chronic illnesses.
- History of bulimia or anorexia.
- Pregnancy or lactation.
Key Trial Info
Start Date :
April 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2023
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT06215196
Start Date
April 14 2023
End Date
August 20 2023
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of New Medical Technologies
Novosibirsk, Novosibisk Region, Russia, 630090